Extension of the distribution agreement between Credo Diagnostics Biomedical Pte Ltd and BIOSYNEX S.A.
BIOSYNEX (ISIN : FR0011005933, Mnémonique :ALBIO), a ma […]
BIOSYNEX (ISIN : FR0011005933, Mnémonique :ALBIO), a ma […]
Focusing on research and development of revolutionary diagnostic technologies since 2011, Credo Diagnostics develops, manufactures, and commercializes accurate, rapid, and affordable molecular diagnostic solutions at the Point-Of-Care testing.
© 2023 | Credo Diagnostics Biomedical Pte. Ltd.